Pitch deck: SparingVision raises $75 million for CRISPR eye treatments · page 9 of 20
The slide uses conceptual line charts to illustrate the difference between restorative gene therapy (like Luxturna) and neuroprotective/slowing therapies (like SPVN06).
Pitch deck · solution · present_solution · sparse density
Slide locked Sign in to view
Slide schematic 4/4
chart 2/2 legend 1/1 title 1/1
Components 4
line line legend headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1